| |
| |
|
| Insider
Information: |
Kapusta Matthew C |
| Relationship: |
Director |
| City: |
Germantown |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
620,901 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,141,678 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
620,901 |
|
|
| Total
Value |
$3,141,678 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
10
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
8
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -299.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Angiodynamics Inc |
ANGO |
SVP, Business Developm... |
2014-11-17 |
30,062 |
2012-04-10 |
0 |
Premium* |
|
|
uniQure B.V. |
QURE |
CEO, Managing Director... |
2024-03-01 |
590,839 |
2017-12-13 |
0 |
Premium* |
|
|
Decibel Therapeutics, Inc. |
DBTX |
Director |
2023-09-25 |
0 |
2023-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
79 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANGO |
Angiodynamics Inc |
SVP, Business Development |
• – – |
2012-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
21,000 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP, Business Development |
• – – |
2013-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,438 |
24,550 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP, Business Development |
• – – |
2014-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,805 |
31,810 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2017-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
271,185 |
271,185 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2018-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
31,374 |
478,933 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2019-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
69,349 |
509,113 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
27,713 |
292,254 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
33,789 |
318,542 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
55,813 |
278,751 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO and Managing Director |
• • – |
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
125,073 |
370,749 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, Managing Director |
• • – |
2023-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,830 |
374,311 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, Managing Director |
• • – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
121,500 |
495,811 |
0 |
- |
|
| DBTX |
Decibel Therapeutics, Inc... |
Director |
– • – |
2023-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| DBTX |
Decibel Therapeutics, Inc... |
Director |
– • – |
2023-09-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, Managing Director |
• • – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
590,839 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, Managing Director |
• • – |
2024-02-26 |
4 |
S |
$6.35 |
$177,190 |
D/D |
(27,904) |
440,839 |
0 |
% |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2019-12-18 |
4 |
OE |
$7.53 |
$55,263 |
D/D |
7,339 |
374,991 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2020-03-18 |
4 |
OE |
$7.53 |
$42,364 |
D/D |
5,626 |
324,168 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2020-04-22 |
4 |
OE |
$7.53 |
$70,601 |
D/D |
9,376 |
327,918 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2020-11-18 |
4 |
OE |
$7.53 |
$24,216 |
D/D |
3,216 |
283,780 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2020-11-19 |
4 |
OE |
$7.53 |
$23,531 |
D/D |
3,125 |
276,592 |
0 |
- |
|
| QURE |
uniQure B.V. |
CEO, CFO, Managing Director |
• • – |
2020-12-16 |
4 |
OE |
$7.53 |
$94,133 |
D/D |
12,501 |
277,738 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP, Business Development |
• – – |
2012-11-15 |
4 |
D |
$10.12 |
$13,743 |
D/D |
(1,358) |
19,642 |
0 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP, Business Development |
• – – |
2012-04-10 |
4 |
B |
$11.40 |
$11,397 |
D/D |
1,000 |
16,000 |
2.74 |
- |
|
| ANGO |
Angiodynamics Inc |
SVP, Business Development |
• – – |
2013-08-03 |
4 |
D |
$12.04 |
$6,381 |
D/D |
(530) |
19,112 |
0 |
- |
|
79 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
